{"id":15653,"date":"2020-07-08T07:01:20","date_gmt":"2020-07-08T05:01:20","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=15653"},"modified":"2020-07-08T07:01:20","modified_gmt":"2020-07-08T05:01:20","slug":"lietuva-isigys-vaisto-koronavirusui-gydyti","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2020\/07\/08\/lietuva-isigys-vaisto-koronavirusui-gydyti\/","title":{"rendered":"Lietuva \u012fsigys vaisto koronavirusui gydyti"},"content":{"rendered":"<div class=\"news_photo_wrapper\"><img data-recalc-dims=\"1\" decoding=\"async\" class=\"news_photo\" src=\"https:\/\/i0.wp.com\/sam.lrv.lt\/uploads\/sam\/news\/images\/852x536_crop\/16797_a0705d7c03e6d0c05e06d9457613beb1.jpg?w=1200\" alt=\"16430_7e5137a1544e914f3ff11137c4978cf5.jpg\" \/><\/div>\n<p><b>Lietuva planuoja \u012fsigyti antivirusinio vaisto remdesiviro, skirto koronaviruso infekcijai (COVID-19 ligai) gydyti. Dalis suplanuoto vaisto kiekio bus perkama centralizuotai, t. y. kartu su kitomis Europos S\u0105jungos (ES) valstyb\u0117mis, kit\u0105 dal\u012f Lietuva \u012fsigys individualiai. M\u016bs\u0173 \u0161alies poreikis yra daugiau nei 2,4 t\u016bkst. ampuli\u0173 remdesiviro, \u0161iuo metu yra siekiama \u012fsigyti kiek daugiau nei 700 ampuli\u0173.<\/b><\/p>\n<p>Lietuvos sprendim\u0105 \u012fsigyti \u0161io vaisto l\u0117m\u0117 tai, kad pra\u0117jusi\u0105 savait\u0119 Europos Komisija (EK), atsi\u017evelgdama \u012f 2020 met\u0173 bir\u017eelio 25 d.\u00a0Europos vaist\u0173 agent\u016bros (EVA) \u017dmon\u0117ms skirt\u0173 vaist\u0173 komiteto rekomendacij\u0105,\u00a0pritar\u0117 remdesiviro, skirto gydyti COVID-19 lig\u0105, registracijai.<\/p>\n<p>Remdesivir\u0105 rekomenduota naudoti gydant koronaviruso infekcij\u0105 suaugusiems ir paaugliams nuo 12 met\u0173, kuriems liga pasirei\u0161k\u0117 plau\u010di\u0173 u\u017edegimu ir d\u0117l to reikia papildomo deguonies. Komercinis vaisto remdesiviro pavadinimas \u2013 \u201eVeklury\u201c.<\/p>\n<p>Remdesiviras yra leid\u017eiamas infuzijos b\u016bdu (la\u0161inamas) \u012f ven\u0105. I\u0161 prad\u017ei\u0173 jis buvo sukurtas Ebolos viruso sukeltai ligai gydyti.<\/p>\n<p>Remdesiviras yra pirmas vaistas, kur\u012f \u017dmon\u0117ms skirt\u0173 vaist\u0173 komitetas rekomendavo registruoti ES. Remdesiviro veiksmingumo ir saugumo duomenys buvo \u012fvertinti i\u0161kirtinai greitai, pasinaudojant t\u0119stin\u0117s per\u017ei\u016bros proced\u016bra, kuri skirta b\u016btent tokioms skubioms situacijoms, kai duomenys vertinami tik jiems pasirod\u017eius. Komitetas informacij\u0105 apie vaisto veiksmingum\u0105 ir saugum\u0105 prad\u0117jo vertinti nuo \u0161. m. baland\u017eio 30 d.<\/p>\n<p>&nbsp;<\/p>\n<p><i>Visuomen\u0117s informavimo grup\u0117s (VIG) informacija<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lietuva planuoja \u012fsigyti antivirusinio vaisto remdesiviro, skirto koronaviruso infekcijai (COVID-19 ligai) gydyti. Dalis suplanuoto vaisto kiekio bus perkama centralizuotai, t. y. kartu su kitomis Europos S\u0105jungos (ES) valstyb\u0117mis, kit\u0105 dal\u012f Lietuva \u012fsigys individualiai. M\u016bs\u0173 \u0161alies poreikis yra daugiau nei 2,4 t\u016bkst. ampuli\u0173 remdesiviro, \u0161iuo metu yra siekiama \u012fsigyti kiek daugiau nei 700 ampuli\u0173. Lietuvos sprendim\u0105&hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-15653","post","type-post","status-publish","format-standard","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-44t","jetpack_featured_media_url":"","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/15653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=15653"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/15653\/revisions"}],"predecessor-version":[{"id":15654,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/15653\/revisions\/15654"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=15653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=15653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=15653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}